Equipment: a mixed picture as companies see divergent sales trajectory Global Research ab 6 February 2026 First Read China Medtech Q425 read-across: many global firms maintain a cautious view on 2026 China outlook Another quarter of weak China results; challenges to linger especially for Dx Many large-cap global medtech companies continue to report YoY decline of China revenue in Q425, especially for diagnostics (Dx) business. Dx companies generally believes that the policy headwinds are likely to linger in ...